Luciole Medical has established a first-mover position in brain monitoring by providing a complete solution to measure brain function parameters in a broad range of hospital settings, from surgeries and anesthesia to neurocritical care.
Luciole Medical’s adhesive patch, intracranial probe and end-to-end analytics platform that can integrate information from additional sources, provide an array of tools to achieve unparalleled real-time data capture of cerebral oxygenation, an important predictor of brain function. It is the only company with a patch and a patented technology that can also measure blood flow in the brain.
The company is also developing a wearable brain monitoring device that can precisely monitor and track brain health.
Luciole Medical’s goal is to transform the current paradigm of brain monitoring to be at the forefront of a revolution in individualized brain health.
Luciole Medical AG was founded in Zürich, Switzerland and is applying a deep understanding of brain hemodynamics to the brain monitoring space. The company is led by an experienced management team and a Board with seasoned medtech executives and entrepreneurs.
The company is privately funded and is regularily looking for further investments in order to accelerate its development.
A company presentation can be found via the following link: